NDC11 62332040331
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 62332-0403-31 | 62332-0403 |
| 62332-403-31 | 62332-403 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NADOLOL | NADOLOL | Alembic Pharmaceuticals Inc. | 6ab029aa-dfe0-4abb-8c7f-2692fe6a2368 | 2024-01-08 | Warnings, Adverse reactions | 62332-403-31 62332-403 62332040331 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.